ONTOLOGY REPORT - ANNOTATIONS
| Term: | ozone |
|
| Accession: | CHEBI:25812
|
browse the term
|
| Definition: | A triatomic oxygen that has formula O3. |
| Synonyms: | exact_synonym: | trioxygen |
| | related_synonym: | InChI=1S/O3/c1-3-2; InChIKey=CBENFWSGALASAD-UHFFFAOYSA-N; O3; Ozon; Trisauerstoff; [O-][O+]=O; [OO2]; ozono; trioxygene |
| | xref_casrn: | 10028-15-6 |
| | xref: | ChemIDplus:10028-15-6 "CAS Registry Number"; Gmelin:1101 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D010126 |
| | xref: | MolBase:931 "MolBase"; NIST Chemistry WebBook:10028-15-6 "CAS Registry Number" |
|
|
ozone
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
decreases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
multiple interactions |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acer2 |
alkaline ceramidase 2 |
|
decreases expression |
ISO |
5 |
106,185,779 |
106,237,588 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
decreases expression |
ISO |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
multiple interactions |
EXP |
5 |
169,409,306 |
169,501,907 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
decreases expression |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
ISO |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Acvr1 |
activin A receptor, type I |
|
multiple interactions |
EXP |
3 |
40,191,727 |
40,260,488 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
increases expression |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
|
increases expression |
ISO |
13 |
87,142,442 |
87,151,783 |
RGD:6480464 |
CTD |
| G |
Adcy2 |
adenylate cyclase 2 (brain) |
|
multiple interactions |
EXP |
17 |
4,543,466 |
5,040,433 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
multiple interactions |
EXP |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adcy4 |
adenylate cyclase 4 |
|
decreases expression |
ISO |
15 |
33,930,531 |
33,946,352 |
RGD:6480464 |
CTD |
| G |
Adcy4 |
adenylate cyclase 4 |
|
multiple interactions |
EXP |
15 |
33,930,531 |
33,946,352 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
multiple interactions |
EXP |
11 |
67,290,968 |
67,437,468 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
multiple interactions |
EXP |
7 |
101,957,807 |
102,210,346 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
EXP |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adora3 |
adenosine A3 receptor |
|
multiple interactions |
EXP |
2 |
201,157,782 |
201,161,425 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
multiple interactions |
EXP |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects response to substance |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
decreases expression |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects localization |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
multiple interactions |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
multiple interactions |
EXP |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Brwd3 |
bromodomain and WD repeat domain containing 3 |
|
multiple interactions |
ISO |
X |
97,008,947 |
97,131,275 |
RGD:6480464 |
CTD |
| G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
|
increases expression |
ISO |
9 |
57,053,423 |
57,065,699 |
RGD:6480464 |
CTD |
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
decreases expression |
ISO |
10 |
28,571,051 |
28,588,714 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
decreases expression |
EXP |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
multiple interactions |
EXP |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
EXP |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
decreases expression |
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
EXP |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Calml5 |
calmodulin-like 5 |
|
decreases expression |
ISO |
17 |
77,567,314 |
77,571,711 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
decreases expression |
EXP |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
multiple interactions |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
multiple interactions |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
multiple interactions |
EXP |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cby1 |
chibby homolog 1 (Drosophila) |
|
decreases expression |
ISO |
7 |
117,903,217 |
117,908,964 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
multiple interactions |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases expression |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases expression |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases expression |
EXP |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
ISO |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases response to substance |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
multiple interactions |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
multiple interactions |
EXP |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
multiple interactions |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ckmt2 |
creatine kinase, mitochondrial 2, sarcomeric |
|
decreases expression |
ISO |
2 |
22,084,948 |
22,106,014 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
multiple interactions |
ISO |
13 |
111,010,296 |
111,057,427 |
RGD:6480464 |
CTD |
| G |
Cr2 |
complement component (3d/Epstein Barr virus) receptor 2 |
|
multiple interactions |
ISO |
13 |
111,078,338 |
111,113,667 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
decreases expression |
ISO |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
multiple interactions |
EXP |
4 |
83,839,822 |
83,867,017 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
multiple interactions |
EXP |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
multiple interactions |
EXP |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
decreases expression |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
decreases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csn3 |
casein kappa |
|
decreases expression |
ISO |
14 |
21,674,805 |
21,681,360 |
RGD:6480464 |
CTD |
| G |
Csnk1g1 |
casein kinase 1, gamma 1 |
|
multiple interactions |
EXP |
8 |
70,193,231 |
70,301,592 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
decreases expression |
ISO |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
multiple interactions |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Ctla2a |
cytotoxic T lymphocyte-associated protein 2 alpha |
|
decreases expression |
ISO |
17 |
9,489,385 |
9,491,270 |
RGD:6480464 |
CTD |
| G |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
|
decreases expression |
ISO |
4 |
110,747,551 |
111,922,482 |
RGD:6480464 |
CTD |
| G |
Ctps |
CTP synthase |
|
multiple interactions |
ISO |
5 |
141,136,686 |
141,165,817 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
EXP |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cuta |
cutA divalent cation tolerance homolog (E. coli) |
|
decreases expression |
ISO |
20 |
5,175,113 |
5,176,689 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
decreases expression |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases response to substance |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
decreases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
decreases expression |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
multiple interactions |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
decreases expression |
ISO |
20 |
4,021,679 |
4,033,709 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
multiple interactions |
EXP |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
decreases expression |
ISO |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
EXP |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Eln |
elastin |
|
increases expression |
EXP |
12 |
23,033,657 |
23,077,043 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
ELOVL fatty acid elongase 3 |
|
decreases expression |
ISO |
1 |
251,351,908 |
251,355,736 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
decreases expression |
ISO |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
Epha3 |
Eph receptor A3 |
|
decreases expression |
EXP |
11 |
696,185 |
1,033,287 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
decreases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
multiple interactions |
ISO |
16 |
8,024,881 |
8,091,587 |
RGD:6480464 |
CTD |
| G |
Ereg |
epiregulin |
|
increases expression |
EXP |
14 |
18,521,069 |
18,534,844 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
multiple interactions |
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D |
|
increases expression |
ISO |
15 |
55,556,681 |
55,576,172 |
RGD:6480464 |
CTD |
| G |
Evl |
Enah/Vasp-like |
|
decreases expression |
ISO |
6 |
132,952,804 |
133,019,870 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
EXP |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases activity |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
multiple interactions |
ISO |
16 |
81,348,678 |
81,358,991 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
multiple interactions |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
increases expression |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
multiple interactions |
EXP |
2 |
219,591,502 |
219,605,097 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
decreases expression |
ISO |
5 |
149,340,525 |
149,347,268 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
multiple interactions |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
increases expression |
EXP |
13 |
87,119,464 |
87,123,902 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
decreases expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
increases expression |
ISO |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fem1b |
fem-1 homolog b (C. elegans) |
|
multiple interactions |
ISO |
8 |
66,948,714 |
66,961,986 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
multiple interactions |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
decreases expression |
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
72,242,271 |
72,243,353 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
multiple interactions |
EXP |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Fignl1 |
fidgetin-like 1 |
|
multiple interactions |
ISO |
14 |
92,685,445 |
92,693,967 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
increases expression |
ISO |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
affects expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
|
increases expression |
EXP |
1 |
86,076,279 |
86,085,681 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
decreases expression |
ISO |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
Fzd4 |
frizzled family receptor 4 |
|
decreases expression |
ISO |
1 |
145,953,743 |
145,957,666 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
decreases expression |
ISO |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
decreases expression |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
|
decreases expression |
ISO |
2 |
95,174,030 |
95,176,430 |
RGD:6480464 |
CTD |
| G |
Hipk3 |
homeodomain interacting protein kinase 3 |
|
increases expression |
ISO |
3 |
89,749,949 |
89,816,787 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
increases expression |
ISO |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
multiple interactions |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases response to substance |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
increases expression |
ISO |
14 |
10,861,054 |
10,864,322 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeo box B4 |
|
decreases expression |
ISO |
10 |
85,050,695 |
85,053,277 |
RGD:6480464 |
CTD |
| G |
Hpcal4 |
hippocalcin-like 4 |
|
multiple interactions |
EXP |
5 |
142,490,462 |
142,498,359 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
decreases expression |
ISO |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hpx |
hemopexin |
|
multiple interactions |
ISO |
1 |
163,319,509 |
163,327,017 |
RGD:6480464 |
CTD |
| G |
Hpx |
hemopexin |
|
increases expression |
ISO |
1 |
163,319,509 |
163,327,017 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
|
decreases expression |
ISO |
3 |
78,436,634 |
78,559,707 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
multiple interactions |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
decreases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein B8 |
|
multiple interactions |
ISO |
12 |
41,407,166 |
41,421,565 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Htr1f |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
|
multiple interactions |
EXP |
11 |
2,260,587 |
2,261,687 |
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
EXP |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ide |
insulin degrading enzyme |
|
decreases expression |
ISO |
1 |
241,547,869 |
241,646,052 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
decreases expression |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Ids |
iduronate 2-sulfatase |
|
increases expression |
ISO |
X |
156,641,266 |
156,661,031 |
RGD:6480464 |
CTD |
| G |
Ier5 |
immediate early response 5 |
|
increases expression |
EXP |
13 |
70,058,818 |
70,060,910 |
RGD:6480464 |
CTD |
| G |
Ifi203-ps1 |
interferon activated gene 203, pseudogene 1 |
|
decreases expression |
ISO |
13 |
89,711,997 |
89,729,593 |
RGD:6480464 |
CTD |
| G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
decreases expression |
ISO |
6 |
127,725,194 |
127,731,665 |
RGD:6480464 |
CTD |
| G |
Ifi47 |
interferon gamma inducible protein 47 |
|
decreases expression |
ISO |
10 |
34,197,630 |
34,205,133 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
decreases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
decreases expression |
ISO |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Ifitm6 |
interferon induced transmembrane protein 6 |
|
multiple interactions |
ISO |
1 |
201,204,645 |
201,205,945 |
RGD:6480464 |
CTD |
| G |
Ifitm6 |
interferon induced transmembrane protein 6 |
|
multiple interactions |
ISO |
1 |
201,204,645 |
201,205,945 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
increases expression |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
multiple interactions |
EXP |
10 |
14,127,416 |
14,130,662 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
decreases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
decreases expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
decreases expression |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
increases response to substance |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
EXP |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
multiple interactions |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
increases response to substance |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
increases expression |
EXP |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
multiple interactions |
EXP |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
multiple interactions |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
increases expression |
EXP |
13 |
43,831,510 |
43,836,908 |
RGD:6480464 |
CTD |
| G |
Il2rg |
interleukin 2 receptor, gamma |
|
decreases expression |
ISO |
X |
89,342,055 |
89,345,715 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
decreases expression |
ISO |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
decreases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases response to substance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
decreases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
EXP |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Insrr |
insulin receptor-related receptor |
|
multiple interactions |
EXP |
2 |
179,857,189 |
179,876,572 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
decreases expression |
ISO |
13 |
108,986,973 |
109,006,180 |
RGD:6480464 |
CTD |
| G |
Irf9 |
interferon regulatory factor 9 |
|
decreases expression |
ISO |
15 |
33,739,755 |
33,744,958 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin, alpha 1 |
|
multiple interactions |
EXP |
2 |
47,107,849 |
47,206,261 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
EXP |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
increases expression |
EXP |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
multiple interactions |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases response to substance |
EXP |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
multiple interactions |
EXP |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
|
decreases expression |
ISO |
4 |
183,677,606 |
184,066,130 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
|
multiple interactions |
EXP |
20 |
5,292,430 |
5,357,502 |
RGD:6480464 |
CTD |
| G |
Ivns1abp |
influenza virus NS1A binding protein |
|
decreases expression |
ISO |
13 |
66,228,241 |
66,235,533 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
multiple interactions |
EXP |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
multiple interactions |
EXP |
3 |
92,781,795 |
92,784,921 |
RGD:6480464 |
CTD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
multiple interactions |
EXP |
3 |
158,250,001 |
158,345,927 |
RGD:6480464 |
CTD |
| G |
Kcnc2 |
potassium voltage gated channel, Shaw-related subfamily, member 2 |
|
increases expression |
EXP |
7 |
51,326,602 |
51,487,958 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
multiple interactions |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
decreases expression |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcne4 |
potassium voltage-gated channel, Isk-related family, member 4 |
|
multiple interactions |
ISO |
9 |
78,200,904 |
78,202,092 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
multiple interactions |
EXP |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
decreases expression |
EXP |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
multiple interactions |
EXP |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
multiple interactions |
EXP |
4 |
180,144,084 |
180,149,935 |
RGD:6480464 |
CTD |
| G |
Kcnk1 |
potassium channel, subfamily K, member 1 |
|
increases expression |
ISO |
19 |
56,216,600 |
56,255,299 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif22 |
kinesin family member 22 |
|
multiple interactions |
ISO |
1 |
186,205,162 |
186,293,437 |
RGD:6480464 |
CTD |
| G |
Kif23 |
kinesin family member 23 |
|
multiple interactions |
ISO |
8 |
66,050,163 |
66,077,265 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
decreases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klf15 |
Kruppel-like factor 15 |
|
decreases expression |
EXP |
4 |
124,714,395 |
124,726,991 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
multiple interactions |
ISO |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
decreases expression |
ISO |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klhl2 |
kelch-like family member 2 |
|
multiple interactions |
ISO |
16 |
26,634,400 |
26,690,756 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
decreases expression |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Klkb1 |
kallikrein B, plasma 1 |
|
multiple interactions |
EXP |
16 |
50,248,935 |
50,272,279 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
increases expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
multiple interactions |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases expression |
EXP |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
multiple interactions |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
multiple interactions |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
decreases expression |
ISO |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
EXP |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases response to substance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases response to substance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
increases response to substance |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lhx5 |
LIM homeobox 5 |
|
decreases expression |
ISO |
12 |
37,323,820 |
37,332,257 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
decreases expression |
EXP |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
multiple interactions |
EXP |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
decreases expression |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
multiple interactions |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
decreases expression |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lmo2 |
LIM domain only 2 |
|
decreases expression |
ISO |
3 |
89,356,199 |
89,367,641 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
increases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
multiple interactions |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
multiple interactions |
EXP |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lpin2 |
lipin 2 |
|
increases expression |
ISO |
9 |
110,380,692 |
110,484,329 |
RGD:6480464 |
CTD |
| G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
|
increases expression |
ISO |
4 |
85,656,850 |
85,660,066 |
RGD:6480464 |
CTD |
| G |
Lst1 |
leukocyte specific transcript 1 |
|
decreases expression |
ISO |
20 |
3,698,568 |
3,701,564 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin beta (TNF superfamily, member 3) |
|
decreases expression |
ISO |
20 |
3,666,524 |
3,668,369 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ly6d |
lymphocyte antigen 6 complex, locus D |
|
decreases expression |
ISO |
7 |
112,872,991 |
112,874,499 |
RGD:6480464 |
CTD |
| G |
Ly86 |
lymphocyte antigen 86 |
|
decreases expression |
ISO |
17 |
33,667,680 |
33,768,108 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
multiple interactions |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
decreases expression |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
|
decreases expression |
ISO |
8 |
80,446,544 |
80,462,607 |
RGD:6480464 |
CTD |
| G |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
|
multiple interactions |
ISO |
4 |
96,380,039 |
96,386,042 |
RGD:6480464 |
CTD |
| G |
Magix |
MAGI family member, X-linked |
|
decreases expression |
ISO |
X |
26,865,047 |
26,871,907 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
multiple interactions |
ISO |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
multiple interactions |
EXP |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
increases expression |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
multiple interactions |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
decreases expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
decreases expression |
EXP |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mat1a |
methionine adenosyltransferase I, alpha |
|
increases expression |
ISO |
16 |
17,548,582 |
17,563,989 |
RGD:6480464 |
CTD |
| G |
Max |
MYC associated factor X |
|
multiple interactions |
EXP |
6 |
99,529,905 |
99,553,851 |
RGD:6480464 |
CTD |
| G |
Mb |
myoglobin |
|
decreases expression |
ISO |
7 |
115,087,558 |
115,094,789 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
multiple interactions |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mc4r |
melanocortin 4 receptor |
|
multiple interactions |
EXP |
18 |
63,390,922 |
63,392,809 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
increases expression |
EXP |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
multiple interactions |
EXP |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
decreases expression |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
multiple interactions |
EXP |
X |
159,980,599 |
160,035,260 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
multiple interactions |
EXP |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmp11 |
matrix metallopeptidase 11 |
|
decreases expression |
EXP |
20 |
13,129,667 |
13,138,449 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
increases expression |
ISO |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
EXP |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp8 |
matrix metallopeptidase 8 |
|
increases expression |
ISO |
8 |
4,402,124 |
4,410,976 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases activity |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases response to substance |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mr1 |
major histocompatibility complex, class I-related |
|
decreases expression |
ISO |
13 |
70,089,637 |
70,107,384 |
RGD:6480464 |
CTD |
| G |
Mrgprf |
MAS-related GPR, member F |
|
multiple interactions |
EXP |
1 |
205,750,528 |
205,759,996 |
RGD:6480464 |
CTD |
| G |
Mrpl54 |
mitochondrial ribosomal protein L54 |
|
increases expression |
ISO |
7 |
9,936,603 |
9,939,123 |
RGD:6480464 |
CTD |
| G |
Ms4a2 |
membrane-spanning 4-domains, subfamily A, member 2 |
|
multiple interactions |
ISO |
1 |
214,011,050 |
214,018,999 |
RGD:6480464 |
CTD |
| G |
Ms4a2 |
membrane-spanning 4-domains, subfamily A, member 2 |
|
affects response to substance |
ISO |
1 |
214,011,050 |
214,018,999 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases expression |
EXP |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msln |
mesothelin |
|
increases expression |
ISO |
10 |
15,017,162 |
15,022,823 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
decreases expression |
ISO |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects response to substance |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects response to substance |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mtnr1a |
melatonin receptor 1A |
|
multiple interactions |
EXP |
16 |
50,439,407 |
50,458,585 |
RGD:6480464 |
CTD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
decreases expression |
ISO |
2 |
235,613,710 |
235,654,848 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
multiple interactions |
EXP |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mycs |
myc-like oncogene, s-myc protein |
|
multiple interactions |
EXP |
X |
28,062,010 |
28,063,302 |
RGD:6480464 |
CTD |
| G |
Myct1 |
myc target 1 |
|
decreases expression |
ISO |
1 |
36,314,335 |
36,325,608 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
multiple interactions |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
decreases response to substance |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
increases expression |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myh10 |
myosin, heavy chain 10, non-muscle |
|
decreases expression |
ISO |
10 |
55,445,288 |
55,576,096 |
RGD:6480464 |
CTD |
| G |
Myh2 |
myosin, heavy chain 2, skeletal muscle, adult |
|
multiple interactions |
ISO |
10 |
53,864,777 |
53,891,711 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
decreases expression |
ISO |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Myl1 |
myosin, light chain 1 |
|
decreases expression |
ISO |
9 |
65,717,097 |
65,737,576 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
decreases expression |
ISO |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Myl3 |
myosin, light chain 3, alkali; ventricular, skeletal, slow |
|
decreases expression |
ISO |
8 |
115,140,705 |
115,146,827 |
RGD:6480464 |
CTD |
| G |
Myl4 |
myosin, light chain 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myl7 |
myosin, light chain 7, regulatory |
|
decreases expression |
ISO |
14 |
86,568,142 |
86,570,122 |
RGD:6480464 |
CTD |
| G |
Myo1b |
myosin Ib |
|
multiple interactions |
EXP |
9 |
46,756,678 |
46,917,169 |
RGD:6480464 |
CTD |
| G |
Myom1 |
myomesin 1 |
|
increases expression |
ISO |
9 |
110,218,668 |
110,341,029 |
RGD:6480464 |
CTD |
| G |
Nap1l4 |
nucleosome assembly protein 1-like 4 |
|
increases expression |
ISO |
1 |
203,890,799 |
203,926,237 |
RGD:6480464 |
CTD |
| G |
Ncapg2 |
non-SMC condensin II complex, subunit G2 |
|
multiple interactions |
ISO |
6 |
143,693,508 |
143,751,084 |
RGD:6480464 |
CTD |
| G |
Ncbp2 |
nuclear cap binding protein subunit 2 |
|
decreases expression |
ISO |
11 |
70,642,907 |
70,651,744 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Nell1 |
NEL-like 1 (chicken) |
|
multiple interactions |
EXP |
1 |
99,805,922 |
100,758,002 |
RGD:6480464 |
CTD |
| G |
Nell2 |
NEL-like 2 (chicken) |
|
multiple interactions |
EXP |
7 |
133,758,271 |
134,080,104 |
RGD:6480464 |
CTD |
| G |
Net1 |
neuroepithelial cell transforming 1 |
|
decreases expression |
ISO |
17 |
77,533,225 |
77,543,337 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
|
increases expression |
ISO |
17 |
18,092,489 |
18,107,708 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
decreases expression |
ISO |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
multiple interactions |
EXP |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases response to substance |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
multiple interactions |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Npr3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
increases expression |
ISO |
2 |
61,278,264 |
61,341,460 |
RGD:6480464 |
CTD |
| G |
Nptxr |
neuronal pentraxin receptor |
|
multiple interactions |
EXP |
7 |
118,023,653 |
118,041,729 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases response to substance |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
decreases expression |
ISO |
10 |
87,541,246 |
87,548,186 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
multiple interactions |
ISO |
10 |
87,541,246 |
87,548,186 |
RGD:6480464 |
CTD |
| G |
Nr2c2 |
nuclear receptor subfamily 2, group C, member 2 |
|
multiple interactions |
EXP |
4 |
126,319,412 |
126,344,808 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
multiple interactions |
EXP |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
multiple interactions |
EXP |
19 |
32,527,752 |
32,875,369 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions |
EXP |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
increases expression |
EXP |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
|
decreases expression |
ISO |
13 |
49,931,592 |
50,048,756 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrn1 |
neuritin 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nrp2 |
neuropilin 2 |
|
multiple interactions |
EXP |
9 |
61,348,529 |
61,460,457 |
RGD:6480464 |
CTD |
| G |
Nrxn1 |
neurexin 1 |
|
multiple interactions |
EXP |
6 |
14,050,929 |
15,354,069 |
RGD:6480464 |
CTD |
| G |
Nrxn2 |
neurexin 2 |
|
multiple interactions |
EXP |
1 |
209,211,740 |
209,318,064 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
multiple interactions |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Ntsr2 |
neurotensin receptor 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
13 |
85,286,634 |
85,315,366 |
RGD:6480464 |
CTD |
| G |
Nusap1 |
nucleolar and spindle associated protein 1 |
|
multiple interactions |
ISO |
3 |
106,134,200 |
106,165,155 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
multiple interactions |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Ogn |
osteoglycin |
|
decreases expression |
ISO |
17 |
20,987,029 |
21,007,525 |
RGD:6480464 |
CTD |
| G |
Olr1172 |
olfactory receptor 1172 |
|
multiple interactions |
EXP |
8 |
18,628,573 |
18,629,568 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
increases expression |
ISO |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
multiple interactions |
EXP |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
multiple interactions |
EXP |
1 |
155,057,622 |
155,174,714 |
RGD:6480464 |
CTD |
| G |
Pbk |
PDZ binding kinase |
|
multiple interactions |
ISO |
15 |
45,227,251 |
45,238,096 |
RGD:6480464 |
CTD |
| G |
Pbsn |
probasin |
|
multiple interactions |
EXP |
X |
63,581,742 |
63,597,497 |
RGD:6480464 |
CTD |
| G |
Pcdh18 |
protocadherin 18 |
|
decreases expression |
ISO |
2 |
138,615,496 |
138,629,181 |
RGD:6480464 |
CTD |
| G |
Pcdha6 |
protocadherin alpha 6 |
|
decreases expression |
ISO |
18 |
29,697,876 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
|
decreases expression |
ISO |
13 |
87,059,476 |
87,083,085 |
RGD:6480464 |
CTD |
| G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
|
multiple interactions |
EXP |
8 |
48,879,382 |
48,901,968 |
RGD:6480464 |
CTD |
| G |
Pdap1 |
PDGFA associated protein 1 |
|
multiple interactions |
EXP |
12 |
9,784,744 |
9,794,971 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
decreases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
decreases expression |
EXP |
1 |
172,409,282 |
172,577,108 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
decreases expression |
EXP |
8 |
20,192,677 |
20,241,557 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
multiple interactions |
EXP |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
decreases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
multiple interactions |
EXP |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
multiple interactions |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdlim1 |
PDZ and LIM domain 1 |
|
multiple interactions |
EXP |
1 |
245,350,086 |
245,399,534 |
RGD:6480464 |
CTD |
| G |
Pdpn |
podoplanin |
|
decreases expression |
EXP |
5 |
162,142,251 |
162,175,921 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
decreases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
increases expression |
ISO |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
increases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
increases expression |
ISO |
14 |
84,616,451 |
84,632,831 |
RGD:6480464 |
CTD |
| G |
Pex2 |
peroxisomal biogenesis factor 2 |
|
decreases expression |
ISO |
2 |
98,361,891 |
98,378,715 |
RGD:6480464 |
CTD |
| G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
multiple interactions |
EXP |
8 |
114,012,543 |
114,050,534 |
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
increases expression |
ISO |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Pgap2 |
post-GPI attachment to proteins 2 |
|
multiple interactions |
EXP |
1 |
159,696,924 |
159,722,582 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
ISO |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Pi4ka |
phosphatidylinositol 4-kinase, catalytic, alpha |
|
multiple interactions |
EXP |
11 |
85,610,281 |
85,726,603 |
RGD:6480464 |
CTD |
| G |
Pigm |
phosphatidylinositol glycan anchor biosynthesis, class M |
|
decreases expression |
ISO |
13 |
88,377,212 |
88,380,909 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
decreases expression |
ISO |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pim3 |
pim-3 oncogene |
|
decreases expression |
ISO |
7 |
127,167,984 |
127,172,018 |
RGD:6480464 |
CTD |
| G |
Pkib |
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
|
decreases expression |
EXP |
20 |
36,655,506 |
36,750,474 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
decreases expression |
EXP |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Pla2g2c |
phospholipase A2, group IIC |
|
multiple interactions |
EXP |
5 |
157,536,546 |
157,555,895 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
decreases expression |
ISO |
9 |
13,057,988 |
13,100,289 |
RGD:6480464 |
CTD |
| G |
Plaa |
phospholipase A2, activating protein |
|
increases expression |
EXP |
5 |
114,869,341 |
114,899,356 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
EXP |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
EXP |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
increases expression |
EXP |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcb3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
|
decreases expression |
EXP |
1 |
209,628,425 |
209,643,694 |
RGD:6480464 |
CTD |
| G |
Plcd1 |
phospholipase C, delta 1 |
|
decreases expression |
EXP |
8 |
124,023,090 |
124,052,193 |
RGD:6480464 |
CTD |
| G |
Plcg1 |
phospholipase C, gamma 1 |
|
decreases expression |
EXP |
3 |
151,522,949 |
151,553,998 |
RGD:6480464 |
CTD |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
decreases expression |
EXP |
19 |
47,875,572 |
47,947,573 |
RGD:6480464 |
CTD |
| G |
Plec |
plectin |
|
multiple interactions |
EXP |
7 |
114,202,742 |
114,262,385 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
increases expression |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
EXP |
8 |
97,525,279 |
97,623,152 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
decreases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Plxna2 |
plexin A2 |
|
multiple interactions |
ISO |
13 |
110,555,958 |
110,754,672 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
EXP |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pmvk |
phosphomevalonate kinase |
|
increases expression |
ISO |
2 |
181,655,658 |
181,665,214 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
multiple interactions |
EXP |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
EXP |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pole |
polymerase (DNA directed), epsilon, catalytic subunit |
|
multiple interactions |
ISO |
12 |
46,491,498 |
46,539,988 |
RGD:6480464 |
CTD |
| G |
Polr2c |
polymerase (RNA) II (DNA directed) polypeptide C |
|
decreases expression |
ISO |
19 |
10,597,288 |
10,604,070 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases expression |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
decreases expression |
ISO |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
multiple interactions |
EXP |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects localization |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
|
decreases expression |
ISO |
1 |
164,979,709 |
165,125,077 |
RGD:6480464 |
CTD |
| G |
Ppp1cb |
protein phosphatase 1, catalytic subunit, beta isozyme |
|
decreases expression |
ISO |
6 |
24,067,544 |
24,099,280 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
EXP |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp2cb |
protein phosphatase 2, catalytic subunit, beta isozyme |
|
multiple interactions |
EXP |
16 |
62,330,513 |
62,351,968 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
multiple interactions |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
multiple interactions |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
decreases expression |
EXP |
1 |
64,145,749 |
64,172,712 |
RGD:6480464 |
CTD |
| G |
Prkd2 |
protein kinase D2 |
|
decreases expression |
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:6480464 |
CTD |
| G |
Prmt1 |
protein arginine methyltransferase 1 |
|
multiple interactions |
EXP |
1 |
95,449,061 |
95,458,267 |
RGD:6480464 |
CTD |
| G |
Prss22 |
protease, serine, 22 |
|
increases expression |
ISO |
10 |
13,247,655 |
13,252,365 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
increases expression |
ISO |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
multiple interactions |
ISO |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psen2 |
presenilin 2 |
|
decreases expression |
EXP |
13 |
95,934,674 |
95,951,836 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
multiple interactions |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
multiple interactions |
EXP |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma3l |
proteasome subunit alpha type 3-like |
|
multiple interactions |
EXP |
10 |
93,092,166 |
93,111,072 |
RGD:6480464 |
CTD |
| G |
Psma4 |
proteasome (prosome, macropain) subunit, alpha type 4 |
|
multiple interactions |
EXP |
8 |
58,508,643 |
58,516,103 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
multiple interactions |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
multiple interactions |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb6 |
proteasome (prosome, macropain) subunit, beta type 6 |
|
multiple interactions |
EXP |
10 |
57,370,397 |
57,372,704 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
|
multiple interactions |
EXP |
20 |
4,786,260 |
4,789,223 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
multiple interactions |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
multiple interactions |
EXP |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
multiple interactions |
EXP |
1 |
83,151,149 |
83,159,464 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
multiple interactions |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
multiple interactions |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases activity |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
decreases expression |
EXP |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
multiple interactions |
EXP |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
multiple interactions |
EXP |
12 |
36,501,886 |
36,558,055 |
RGD:6480464 |
CTD |
| G |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
|
increases expression |
ISO |
13 |
106,004,935 |
106,150,162 |
RGD:6480464 |
CTD |
| G |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
|
multiple interactions |
EXP |
13 |
48,094,119 |
48,105,707 |
RGD:6480464 |
CTD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
decreases expression |
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:6480464 |
CTD |
| G |
Ptprcap |
protein tyrosine phosphatase, receptor type, C-associated protein |
|
decreases expression |
ISO |
1 |
206,738,735 |
206,740,894 |
RGD:6480464 |
CTD |
| G |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
|
multiple interactions |
EXP |
7 |
55,324,246 |
55,612,945 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin 3, long |
|
increases expression |
ISO |
2 |
156,089,917 |
156,095,726 |
RGD:6480464 |
CTD |
| G |
Rab15 |
RAB15, member RAS oncogene family |
|
multiple interactions |
EXP |
6 |
99,378,937 |
99,403,340 |
RGD:6480464 |
CTD |
| G |
Rab1a |
RAB1A, member RAS oncogene family |
|
multiple interactions |
EXP |
14 |
100,973,039 |
101,027,893 |
RGD:6480464 |
CTD |
| G |
Rab38 |
RAB38, member RAS oncogene family |
|
decreases expression |
EXP |
1 |
144,783,919 |
144,864,573 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
decreases expression |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rab3b |
RAB3B, member RAS oncogene family |
|
multiple interactions |
EXP |
5 |
130,185,155 |
130,284,038 |
RGD:6480464 |
CTD |
| G |
Rab3d |
RAB3D, member RAS oncogene family |
|
multiple interactions |
EXP |
8 |
21,012,295 |
21,021,327 |
RGD:6480464 |
CTD |
| G |
Rab4a |
RAB4A, member RAS oncogene family |
|
decreases expression |
EXP |
19 |
53,991,122 |
54,019,248 |
RGD:6480464 |
CTD |
| G |
Rab4a |
RAB4A, member RAS oncogene family |
|
multiple interactions |
EXP |
19 |
53,991,122 |
54,019,248 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
increases expression |
ISO |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rala |
v-ral simian leukemia viral oncogene homolog A (ras related) |
|
multiple interactions |
EXP |
17 |
55,017,444 |
55,030,555 |
RGD:6480464 |
CTD |
| G |
Rala |
v-ral simian leukemia viral oncogene homolog A (ras related) |
|
decreases expression |
EXP |
17 |
55,017,444 |
55,030,555 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
multiple interactions |
EXP |
3 |
7,516,054 |
7,537,651 |
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
decreases expression |
ISO |
10 |
90,275,463 |
90,277,242 |
RGD:6480464 |
CTD |
| G |
Rangap1 |
RAN GTPase activating protein 1 |
|
increases expression |
ISO |
7 |
120,056,065 |
120,080,018 |
RGD:6480464 |
CTD |
| G |
Rap2a |
RAS related protein 2a |
|
decreases expression |
ISO |
15 |
105,570,094 |
105,570,584 |
RGD:6480464 |
CTD |
| G |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
|
multiple interactions |
ISO |
3 |
54,396,312 |
54,717,148 |
RGD:6480464 |
CTD |
| G |
Rasa1 |
RAS p21 protein activator (GTPase activating protein) 1 |
|
multiple interactions |
EXP |
2 |
14,203,815 |
14,287,824 |
RGD:6480464 |
CTD |
| G |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
|
decreases expression |
EXP |
10 |
108,492,172 |
108,635,296 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
decreases expression |
EXP |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
|
increases expression |
ISO |
X |
26,379,303 |
26,382,739 |
RGD:6480464 |
CTD |
| G |
Reg1a |
regenerating islet-derived 1 alpha |
|
decreases expression |
ISO |
4 |
112,386,071 |
112,389,205 |
RGD:6480464 |
CTD |
| G |
Reg3a |
regenerating islet-derived 3 alpha |
|
multiple interactions |
ISO |
4 |
112,366,001 |
112,368,767 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
decreases expression |
ISO |
12 |
2,499,630 |
2,501,370 |
RGD:6480464 |
CTD |
| G |
Retnla |
resistin like alpha |
|
multiple interactions |
ISO |
11 |
53,205,246 |
53,206,745 |
RGD:6480464 |
CTD |
| G |
Retnla |
resistin like alpha |
|
multiple interactions |
ISO |
11 |
53,205,246 |
53,206,745 |
RGD:6480464 |
CTD |
| G |
Rims1 |
regulating synaptic membrane exocytosis 1 |
|
multiple interactions |
EXP |
9 |
21,089,088 |
21,594,679 |
RGD:6480464 |
CTD |
| G |
Rin1 |
Ras and Rab interactor 1 |
|
multiple interactions |
EXP |
1 |
207,671,502 |
207,676,150 |
RGD:6480464 |
CTD |
| G |
Rnpep |
arginyl aminopeptidase (aminopeptidase B) |
|
multiple interactions |
EXP |
13 |
48,267,923 |
48,286,295 |
RGD:6480464 |
CTD |
| G |
Rpa2 |
replication protein A2 |
|
increases expression |
EXP |
5 |
152,369,550 |
152,380,370 |
RGD:6480464 |
CTD |
| G |
Rpl10 |
ribosomal protein L10 |
|
multiple interactions |
EXP |
X |
160,336,632 |
160,338,842 |
RGD:6480464 |
CTD |
| G |
Rpl11 |
ribosomal protein L11 |
|
multiple interactions |
EXP |
5 |
154,826,973 |
154,830,183 |
RGD:6480464 |
CTD |
| G |
Rpl12 |
ribosomal protein L12 |
|
multiple interactions |
EXP |
3 |
11,951,921 |
11,954,295 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
multiple interactions |
EXP |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl19 |
ribosomal protein L19 |
|
increases expression |
EXP |
10 |
86,788,838 |
86,792,126 |
RGD:6480464 |
CTD |
| G |
Rpl21 |
ribosomal protein L21 |
|
multiple interactions |
EXP |
12 |
8,716,675 |
8,719,754 |
RGD:6480464 |
CTD |
| G |
Rpl36al |
ribosomal protein L36a-like |
|
multiple interactions |
EXP |
6 |
91,135,710 |
91,137,104 |
RGD:6480464 |
CTD |
| G |
Rps11 |
ribosomal protein S11 |
|
multiple interactions |
EXP |
1 |
95,596,744 |
95,598,852 |
RGD:6480464 |
CTD |
| G |
Rps12 |
ribosomal protein S12 |
|
multiple interactions |
EXP |
1 |
22,265,326 |
22,267,482 |
RGD:6480464 |
CTD |
| G |
Rps17 |
ribosomal protein S17 |
|
multiple interactions |
EXP |
1 |
137,552,232 |
137,554,817 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
multiple interactions |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps29 |
ribosomal protein S29 |
|
multiple interactions |
EXP |
6 |
91,115,709 |
91,117,085 |
RGD:6480464 |
CTD |
| G |
Rps4x |
ribosomal protein S4, X-linked |
|
multiple interactions |
EXP |
X |
34,793,683 |
34,794,576 |
RGD:6480464 |
CTD |
| G |
Rps6ka2 |
ribosomal protein S6 kinase polypeptide 2 |
|
decreases expression |
ISO |
1 |
47,424,106 |
47,560,373 |
RGD:6480464 |
CTD |
| G |
Rrm1-ps1 |
ribonucleotide reductase M1, pseudogene 1 |
|
increases expression |
ISO |
14 |
77,408,781 |
77,411,150 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
RT1-Da |
RT1 class II, locus Da |
|
decreases expression |
EXP |
20 |
4,636,310 |
4,641,282 |
RGD:6480464 |
CTD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
decreases expression |
EXP |
20 |
4,671,489 |
4,681,058 |
RGD:6480464 |
CTD |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
decreases expression |
EXP |
20 |
2,815,943 |
2,820,644 |
RGD:6480464 |
CTD |
| G |
Rtkn2 |
rhotekin 2 |
|
decreases expression |
ISO |
20 |
21,346,889 |
21,434,160 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
decreases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
increases expression |
EXP |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
decreases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
decreases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
decreases expression |
EXP |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
|
multiple interactions |
EXP |
8 |
19,989,867 |
20,000,759 |
RGD:6480464 |
CTD |
| G |
Sc5d |
sterol-C5-desaturase |
|
decreases expression |
ISO |
8 |
45,229,976 |
45,238,924 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
decreases expression |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
decreases expression |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
increases secretion |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
increases expression |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
increases response to substance |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
multiple interactions |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
multiple interactions |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
affects secretion |
EXP |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
increases expression |
EXP |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Scn2b |
sodium channel, voltage-gated, type II, beta |
|
multiple interactions |
EXP |
8 |
48,068,843 |
48,078,632 |
RGD:6480464 |
CTD |
| G |
Scn3b |
sodium channel, voltage-gated, type III, beta |
|
decreases expression |
ISO |
8 |
43,231,453 |
43,254,066 |
RGD:6480464 |
CTD |
| G |
Scn4a |
sodium channel, voltage-gated, type IV, alpha subunit |
|
multiple interactions |
EXP |
10 |
95,710,710 |
95,760,323 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
decreases expression |
EXP |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1, gamma |
|
decreases expression |
EXP |
1 |
180,555,660 |
180,589,534 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
multiple interactions |
EXP |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
decreases expression |
EXP |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Sctr |
secretin receptor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sdpr |
serum deprivation response |
|
decreases expression |
ISO |
9 |
47,373,044 |
47,385,061 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
increases expression |
EXP |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
EXP |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Sept5 |
septin 5 |
|
increases expression |
ISO |
11 |
84,365,193 |
84,370,972 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
increases expression |
ISO |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
multiple interactions |
ISO |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
multiple interactions |
EXP |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sesn1 |
sestrin 1 |
|
decreases expression |
ISO |
20 |
45,786,623 |
45,877,856 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases expression |
ISO |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
multiple interactions |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
multiple interactions |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
increases oxidation |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
multiple interactions |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
affects response to substance |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
increases expression |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
increases oxidation |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
multiple interactions |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sgcg |
sarcoglycan, gamma (dystrophin-associated glycoprotein) |
|
decreases expression |
ISO |
15 |
40,363,607 |
40,410,061 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
multiple interactions |
ISO |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
Sirpa |
signal-regulatory protein alpha |
|
multiple interactions |
EXP |
3 |
117,210,116 |
117,247,840 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
multiple interactions |
EXP |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
|
multiple interactions |
EXP |
18 |
75,071,416 |
75,499,738 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
EXP |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a4 |
solute carrier family 15, member 4 |
|
multiple interactions |
EXP |
12 |
30,111,863 |
30,131,134 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
EXP |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
multiple interactions |
EXP |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
decreases expression |
ISO |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
multiple interactions |
EXP |
7 |
12,393,284 |
12,419,893 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
increases expression |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
EXP |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
multiple interactions |
ISO |
18 |
28,238,953 |
28,250,889 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
increases expression |
ISO |
18 |
28,238,953 |
28,250,889 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
multiple interactions |
ISO |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc26a4 |
solute carrier family 26, member 4 |
|
multiple interactions |
ISO |
6 |
49,389,212 |
49,427,000 |
RGD:6480464 |
CTD |
| G |
Slc27a3 |
solute carrier family 27 (fatty acid transporter), member 3 |
|
decreases expression |
ISO |
2 |
182,643,984 |
182,648,652 |
RGD:6480464 |
CTD |
| G |
Slc28a3 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
|
increases expression |
ISO |
17 |
11,992,175 |
12,042,696 |
RGD:6480464 |
CTD |
| G |
Slc38a4 |
solute carrier family 38, member 4 |
|
increases expression |
ISO |
7 |
135,693,013 |
135,750,703 |
RGD:6480464 |
CTD |
| G |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
|
multiple interactions |
EXP |
4 |
6,100,783 |
6,117,982 |
RGD:6480464 |
CTD |
| G |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
|
decreases expression |
EXP |
4 |
150,067,441 |
150,196,237 |
RGD:6480464 |
CTD |
| G |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
|
multiple interactions |
EXP |
4 |
157,781,178 |
157,800,038 |
RGD:6480464 |
CTD |
| G |
Slc6a15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
|
multiple interactions |
EXP |
7 |
41,498,013 |
41,552,028 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
multiple interactions |
EXP |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
|
increases expression |
EXP |
12 |
7,230,519 |
7,253,858 |
RGD:6480464 |
CTD |
| G |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
|
multiple interactions |
EXP |
12 |
7,230,519 |
7,253,858 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
decreases expression |
EXP |
15 |
32,431,748 |
32,471,526 |
RGD:6480464 |
CTD |
| G |
Slc9a2 |
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
|
multiple interactions |
EXP |
9 |
39,832,184 |
39,916,242 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
decreases expression |
EXP |
8 |
108,012,829 |
108,098,561 |
RGD:6480464 |
CTD |
| G |
Slfn3 |
schlafen 3 |
|
decreases expression |
ISO |
10 |
71,277,765 |
71,301,183 |
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
multiple interactions |
EXP |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smc2 |
structural maintenance of chromosomes 2 |
|
increases expression |
ISO |
5 |
69,561,142 |
69,607,373 |
RGD:6480464 |
CTD |
| G |
Smn1 |
survival of motor neuron 1, telomeric |
|
multiple interactions |
EXP |
2 |
31,147,743 |
31,159,938 |
RGD:6480464 |
CTD |
| G |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
|
decreases expression |
ISO |
20 |
36,821,916 |
36,844,891 |
RGD:6480464 |
CTD |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
multiple interactions |
EXP |
3 |
124,806,637 |
124,894,653 |
RGD:6480464 |
CTD |
| G |
Snrk |
SNF related kinase |
|
decreases expression |
ISO |
8 |
121,958,351 |
121,968,989 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
decreases expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases response to substance |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
ISO |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Spag5 |
sperm associated antigen 5 |
|
increases expression |
ISO |
10 |
64,313,146 |
64,330,975 |
RGD:6480464 |
CTD |
| G |
Spag5 |
sperm associated antigen 5 |
|
multiple interactions |
ISO |
10 |
64,313,146 |
64,330,975 |
RGD:6480464 |
CTD |
| G |
Spast |
spastin |
|
increases expression |
ISO |
6 |
20,990,083 |
21,048,692 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component |
|
multiple interactions |
ISO |
3 |
51,361,185 |
51,374,357 |
RGD:6480464 |
CTD |
| G |
Spon1 |
spondin 1, extracellular matrix protein |
|
multiple interactions |
EXP |
1 |
171,700,495 |
172,020,808 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
increases expression |
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
decreases expression |
EXP |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Ssrp1 |
structure specific recognition protein 1 |
|
multiple interactions |
EXP |
3 |
68,272,947 |
68,282,596 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
multiple interactions |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Sstr3 |
somatostatin receptor 3 |
|
multiple interactions |
EXP |
7 |
116,495,750 |
116,502,948 |
RGD:6480464 |
CTD |
| G |
Stag2 |
stromal antigen 2 |
|
decreases expression |
ISO |
X |
2,840,102 |
2,970,905 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases phosphorylation |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stx1b |
syntaxin 1B |
|
multiple interactions |
EXP |
1 |
187,092,014 |
187,108,481 |
RGD:6480464 |
CTD |
| G |
Stx5 |
syntaxin 5 |
|
multiple interactions |
EXP |
1 |
211,409,653 |
211,426,725 |
RGD:6480464 |
CTD |
| G |
Stx6 |
syntaxin 6 |
|
multiple interactions |
EXP |
13 |
70,121,864 |
70,169,379 |
RGD:6480464 |
CTD |
| G |
Stxbp1 |
syntaxin binding protein 1 |
|
decreases expression |
EXP |
3 |
11,762,105 |
11,825,531 |
RGD:6480464 |
CTD |
| G |
Sucla2 |
succinate-CoA ligase, ADP-forming, beta subunit |
|
decreases expression |
ISO |
15 |
54,214,262 |
54,267,830 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases expression |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
multiple interactions |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult5a1 |
sulfotransferase family 5A, member 1 |
|
decreases expression |
ISO |
19 |
53,472,683 |
53,498,840 |
RGD:6480464 |
CTD |
| G |
Sv2b |
synaptic vesicle glycoprotein 2b |
|
multiple interactions |
EXP |
1 |
130,683,155 |
130,884,752 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
multiple interactions |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syt11 |
synaptotagmin XI |
|
multiple interactions |
ISO |
2 |
180,874,372 |
180,897,792 |
RGD:6480464 |
CTD |
| G |
Syt11 |
synaptotagmin XI |
|
multiple interactions |
EXP |
2 |
180,874,372 |
180,897,792 |
RGD:6480464 |
CTD |
| G |
Syt2 |
synaptotagmin II |
|
multiple interactions |
EXP |
13 |
47,690,518 |
47,699,094 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
multiple interactions |
EXP |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
decreases expression |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
|
multiple interactions |
ISO |
14 |
82,746,460 |
82,760,864 |
RGD:6480464 |
CTD |
| G |
Tacr2 |
tachykinin receptor 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tacr2 |
tachykinin receptor 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
multiple interactions |
EXP |
20 |
4,770,446 |
4,784,488 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
multiple interactions |
EXP |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tc2n |
tandem C2 domains, nuclear |
|
multiple interactions |
ISO |
6 |
125,871,936 |
125,975,388 |
RGD:6480464 |
CTD |
| G |
Tcf19 |
transcription factor 19 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
decreases expression |
ISO |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
decreases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfap2a |
transcription factor AP-2 alpha |
|
multiple interactions |
ISO |
17 |
30,017,580 |
30,034,852 |
RGD:6480464 |
CTD |
| G |
Tfap2a |
transcription factor AP-2 alpha |
|
increases activity |
ISO |
17 |
30,017,580 |
30,034,852 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 |
|
decreases expression |
ISO |
20 |
9,492,341 |
9,510,558 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
decreases expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgoln2 |
trans-golgi network protein 2 |
|
increases expression |
ISO |
4 |
106,110,153 |
106,117,906 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
decreases expression |
ISO |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
increases expression |
EXP |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
|
decreases expression |
ISO |
5 |
138,945,238 |
138,964,631 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
multiple interactions |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
increases expression |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
multiple interactions |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
decreases response to substance |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
decreases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
decreases response to substance |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
decreases response to substance |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases response to substance |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tmem37 |
transmembrane protein 37 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
increases expression |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
multiple interactions |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
multiple interactions |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
affects expression |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
multiple interactions |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
affects expression |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
increases expression |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnnc1 |
troponin C type 1 (slow) |
|
decreases expression |
ISO |
16 |
6,639,357 |
6,642,331 |
RGD:6480464 |
CTD |
| G |
Tnni2 |
troponin I type 2 (skeletal, fast) |
|
multiple interactions |
ISO |
1 |
202,687,630 |
202,690,172 |
RGD:6480464 |
CTD |
| G |
Tnnt1 |
troponin T type 1 (skeletal, slow) |
|
decreases expression |
ISO |
1 |
68,036,411 |
68,045,142 |
RGD:6480464 |
CTD |
| G |
Tnnt3 |
troponin T type 3 (skeletal, fast) |
|
decreases expression |
ISO |
1 |
202,748,063 |
202,761,965 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
multiple interactions |
EXP |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Tpra1 |
transmembrane protein, adipocyte asscociated 1 |
|
decreases expression |
ISO |
4 |
123,001,474 |
123,006,178 |
RGD:6480464 |
CTD |
| G |
Trim37 |
tripartite motif-containing 37 |
|
decreases expression |
ISO |
10 |
75,404,911 |
75,537,072 |
RGD:6480464 |
CTD |
| G |
Tspan4 |
tetraspanin 4 |
|
increases expression |
ISO |
1 |
201,661,391 |
201,681,042 |
RGD:6480464 |
CTD |
| G |
Tspan7 |
tetraspanin 7 |
|
decreases expression |
ISO |
X |
24,362,332 |
24,383,176 |
RGD:6480464 |
CTD |
| G |
Ttpa |
tocopherol (alpha) transfer protein |
|
multiple interactions |
ISO |
5 |
34,638,551 |
34,659,077 |
RGD:6480464 |
CTD |
| G |
Ttpa |
tocopherol (alpha) transfer protein |
|
multiple interactions |
ISO |
5 |
34,638,551 |
34,659,077 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
multiple interactions |
EXP |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
multiple interactions |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
increases expression |
EXP |
10 |
139,578,694 |
139,579,068 |
RGD:6480464 |
CTD |
| G |
Ube2b |
ubiquitin-conjugating enzyme E2B |
|
decreases expression |
ISO |
10 |
37,509,322 |
37,523,900 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Unc5a |
unc-5 homolog A (C. elegans) |
|
decreases expression |
EXP |
17 |
15,670,148 |
15,724,907 |
RGD:6480464 |
CTD |
| G |
Unc5b |
unc-5 homolog B (C. elegans) |
|
multiple interactions |
EXP |
20 |
28,095,243 |
28,162,204 |
RGD:6480464 |
CTD |
| G |
Unc5b |
unc-5 homolog B (C. elegans) |
|
decreases expression |
EXP |
20 |
28,095,243 |
28,162,204 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
multiple interactions |
EXP |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Vgf |
VGF nerve growth factor inducible |
|
decreases expression |
EXP |
12 |
20,903,304 |
20,906,327 |
RGD:6480464 |
CTD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
4 |
149,529,396 |
149,536,289 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
multiple interactions |
EXP |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
decreases expression |
ISO |
3 |
154,748,977 |
154,760,324 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
decreases expression |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
multiple interactions |
EXP |
10 |
63,072,128 |
63,109,833 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
multiple interactions |
EXP |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
multiple interactions |
EXP |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
multiple interactions |
EXP |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
| G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
|
increases expression |
ISO |
8 |
51,931,530 |
52,094,813 |
RGD:6480464 |
CTD |
| G |
Zfp394 |
zinc finger protein 394 |
|
decreases expression |
ISO |
12 |
9,722,094 |
9,730,813 |
RGD:6480464 |
CTD |
| G |
Zrsr2 |
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2 |
|
increases expression |
ISO |
X |
51,304,090 |
51,327,172 |
RGD:6480464 |
CTD |
Term paths to the root
|